Results 91 to 100 of about 20,263 (262)

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Varenicline in the treatment of tobacco dependence

open access: yesNeuropsychiatric Disease and Treatment, 2008
Karl Fagerström1, John Hughes21Smokers Information Centre, Fagerström Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden; 2University of Vermont, Burlington, Vermont, USAAbstract: Varenicline, a partial agonist of α4& ...
Karl Fagerström, John Hughes
doaj  

Identifying determinants of varenicline adherence using the Theoretical Domains framework: a rapid review

open access: yesBMC Public Health
Background Adhering to varenicline has been shown to significantly improve the chances of successfully quitting smoking, with studies indicating a twofold increase in 6-month quit rates.
Nadia Minian   +9 more
doaj   +1 more source

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation

open access: yesHealth Technology Assessment, 2014
Background: Tobacco smoking is one of the leading causes of deaths worldwide. Nearly one-fifth of adults in the UK regularly smoke cigarettes. The ill-health associated with smoking costs the NHS over £3B every year.
Joanna Leaviss   +7 more
doaj   +1 more source

Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism [PDF]

open access: yes, 2016
Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combination, reduces alcohol drinking in alcohol-preferring (P) rats with a genetic predisposition toward high voluntary alcohol intake.
Dilley, Julian E.   +6 more
core   +3 more sources

Beyond the Ocular Surface: Nasal Sensory Input as a Driver of Reflex Lacrimation in Dogs

open access: yesVeterinary Ophthalmology, EarlyView.
ABSTRACT Objective To evaluate the effect of nasal mucosal anesthesia on aqueous tear secretion in dogs and to compare responses between brachycephalic and non‐brachycephalic breeds. Animal Studied Twenty healthy dogs (10 Australian Shepherds, 10 Boston Terriers). Procedures All dogs received 0.5 mL of 10% lidocaine or saline into one randomly selected
Shelley W. Cochran   +2 more
wiley   +1 more source

Nicotine dependence and neuropsychotic effects of varenicline

open access: yesБезопасность и риск фармакотерапии, 2018
Varenicline is a partial agonist of nicotinic acetylcholine receptors for the therapy of nicotine addiction. The efficacy and safety of the use of varenicline in the treatment of nicotine dependence have been demonstrated in clinical trial EAGLES.
T. M. Bukatina   +4 more
doaj   +1 more source

Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan. [PDF]

open access: yesPLoS ONE, 2016
Relative effectiveness of smoking cessation medications-varenicline, bupropion and nicotine replacement therapy (NRT)-remains unclear among smokers in real-world settings.
Po-Yin Chang   +4 more
doaj   +1 more source

Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation [PDF]

open access: yes, 2013
PMCID: PMC3602285This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided ...
Bullen, C   +6 more
core   +1 more source

Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects

open access: yesActa Psychiatrica Scandinavica, Volume 153, Issue 1, Page 54-64, January 2026.
ABSTRACT Background Major psychiatric disorder, including schizophrenia, bipolar disorder, and major depressive disorder, has been individually associated with increased risk of stroke. However, few studies have directly compared the stroke risk across these diagnostic groups within a unified cohort framework while accounting for stroke subtypes and ...
Mao‐Hsuan Huang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy